Navigation Links
Replidyne's Investigational Antibacterial Agent REP3123 Prevents Sporulation in Clostridium difficile
Date:9/19/2007

of action that inhibits growth and targets both sporulation and toxin production, REP3123 could be a future treatment option that tackles the main challenges associated with treating CDAD: high rates of relapse and new outbreaks," stated Kenneth J. Collins, Replidyne's President & CEO. "We are excited by the potential of REP3123 and look forward to its further development."

About Clostridium difficile

C. difficile is a Gram-positive anaerobic bacterium that causes C. difficile-associated disease (CDAD). According to the Centers for Disease Control and Prevention, CDAD is on the rise worldwide, both in terms of number of cases and severity of the disease. Most cases of CDAD occur in a hospital setting due to increased use of antibiotics and other chemotherapeutics that disrupt normal intestinal flora, an ageing population, and difficulty of eradicating C. difficile spores. However, more recently, CDAD has been acquired in the community setting where several outbreaks with increased mortality have occurred. The emergence of an epidemic, hypervirulent C. difficile strain (BI/NAP1, 027) that produces high levels of toxins poses a real threat to public health and demands improved infection control as well as novel treatment options.

About Replidyne, Inc.

Replidyne is a biopharmaceutical company focused on discovering, developing, in-licensing and commercializing innovative anti-infective products. Replidyne's lead product, faropenem medoxomil, is a novel oral, community antibiotic, expected to be appropriate for use as a first-line antibiotic for treatment of respiratory and skin infections in adult and pediatric patients. Replidyne's second drug candidate, REP8839, is a topical anti-infective product candidate in development for the treatment of skin and wound infections, including methicillin-resistant S. aureus (MRSA) infections. Replidyne's investigational antibacterial agent REP3123 targets Gram-positive C. difficile bacteria and related dis
'/>"/>

SOURCE Replidyne, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
3. Late Breaking Data Released at ADA Showed that the Investigational Use of Januvia and Metformin as Initial Combination Therapy Provided Significant Glucose Lowering Efficacy over 54 Weeks in Patients with Type 2 Diabetes
4. Investigational Study Demonstrated a Re-Establishment of Clinical Improvement with Orencia (Abatacept) in Children with Juvenile Idiopathic Arthritis upon Re-Introduction of Therapy
5. Mercks Investigational Migraine Treatment MK-0974 Significantly Improved Migraine Pain on Several Efficacy Measures in a Phase II Study
6. Data Demonstrated Metastatic Melanoma Response to Investigational Immunotherapy Ipilimumab
7. Investigational Drug Cediranib (AZD2171) Shows Promise in Patients With Recurrent Glioblastoma (GBM)
8. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
9. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
10. Investigational Cancer Drug Pertuzumab Shows Promising Results in Advanced Breast Cancer When Combined with Herceptin
11. Shire Announces Positive Results of Studies With Guanfacine Extended Release, An Investigational Nonstimulant Medication Filed for the Treatment of ADHD in Children and Adolescents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Aug. 27, 2014 TWi Pharmaceuticals, Inc. ... from the United States Food and Drug Administration ... for megestrol acetate 125mg/ml oral suspension, the generic ... the first-to-file and under Hatch Waxman rules, it ... exclusivity.  TWi has completed the pre-launch preparation of ...
(Date:8/27/2014)... , Aug. 27, 2014 ... report: Collaborative R&D Terms & ... https://www.reportbuyer.com/product/2276220/Collaborative-RD-Terms--Agreements-in-Pharma-Biotech-and-Diagnostics.html The Collaborative ... and Diagnostics report provides comprehensive understanding and ... and agreements entered into by the worlds ...
(Date:8/27/2014)... , Aug. 27, 2014 ... report: Co-development Terms & Agreements ... https://www.reportbuyer.com/product/2276221/Co-development-Terms--Agreements-in-Pharma-Biotech-and-Diagnostics.html The Co-development ... Diagnostics report provides comprehensive understanding and unprecedented ... entered into by the worlds leading life ...
Breaking Medicine Technology:TWi Pharmaceuticals Receives US FDA Final Approval on Generic Megestrol Acetate 125mg/ml Oral Suspension 2Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics 2Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics 3Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics 4Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics 5Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics 6Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics 7Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics 8Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics 9Co-development Terms & Agreements in Pharma, Biotech and Diagnostics 2Co-development Terms & Agreements in Pharma, Biotech and Diagnostics 3Co-development Terms & Agreements in Pharma, Biotech and Diagnostics 4Co-development Terms & Agreements in Pharma, Biotech and Diagnostics 5Co-development Terms & Agreements in Pharma, Biotech and Diagnostics 6Co-development Terms & Agreements in Pharma, Biotech and Diagnostics 7
... 24, 2011 Bacterin International Holdings, Inc. ... the development of revolutionary bone graft material and antimicrobial coatings ... Singular Research,s Sixth Annual ,Best of the Uncovereds, Conference. The ... in Los Angeles, California. Bacterin,s chairman and CEO ...
... Reportlinker.com announces that a new ... its catalogue: Ophthalmic ... and Cataract Surgery Devices, Minimally Invasive ... the Ophthalmic Surgery Market ...
Cached Medicine Technology:Bacterin to Present at Sixth Annual Singular Research 'Best of the Uncovereds' Conference on October 26, 2011 2Ophthalmic Devices Market to 2017 - Glaucoma and Cataract Surgery Devices, Minimally Invasive Procedures in Ophthalmic Surgery to Drive the Ophthalmic Surgery Market 2Ophthalmic Devices Market to 2017 - Glaucoma and Cataract Surgery Devices, Minimally Invasive Procedures in Ophthalmic Surgery to Drive the Ophthalmic Surgery Market 3Ophthalmic Devices Market to 2017 - Glaucoma and Cataract Surgery Devices, Minimally Invasive Procedures in Ophthalmic Surgery to Drive the Ophthalmic Surgery Market 4Ophthalmic Devices Market to 2017 - Glaucoma and Cataract Surgery Devices, Minimally Invasive Procedures in Ophthalmic Surgery to Drive the Ophthalmic Surgery Market 5Ophthalmic Devices Market to 2017 - Glaucoma and Cataract Surgery Devices, Minimally Invasive Procedures in Ophthalmic Surgery to Drive the Ophthalmic Surgery Market 6Ophthalmic Devices Market to 2017 - Glaucoma and Cataract Surgery Devices, Minimally Invasive Procedures in Ophthalmic Surgery to Drive the Ophthalmic Surgery Market 7Ophthalmic Devices Market to 2017 - Glaucoma and Cataract Surgery Devices, Minimally Invasive Procedures in Ophthalmic Surgery to Drive the Ophthalmic Surgery Market 8Ophthalmic Devices Market to 2017 - Glaucoma and Cataract Surgery Devices, Minimally Invasive Procedures in Ophthalmic Surgery to Drive the Ophthalmic Surgery Market 9Ophthalmic Devices Market to 2017 - Glaucoma and Cataract Surgery Devices, Minimally Invasive Procedures in Ophthalmic Surgery to Drive the Ophthalmic Surgery Market 10Ophthalmic Devices Market to 2017 - Glaucoma and Cataract Surgery Devices, Minimally Invasive Procedures in Ophthalmic Surgery to Drive the Ophthalmic Surgery Market 11Ophthalmic Devices Market to 2017 - Glaucoma and Cataract Surgery Devices, Minimally Invasive Procedures in Ophthalmic Surgery to Drive the Ophthalmic Surgery Market 12Ophthalmic Devices Market to 2017 - Glaucoma and Cataract Surgery Devices, Minimally Invasive Procedures in Ophthalmic Surgery to Drive the Ophthalmic Surgery Market 13Ophthalmic Devices Market to 2017 - Glaucoma and Cataract Surgery Devices, Minimally Invasive Procedures in Ophthalmic Surgery to Drive the Ophthalmic Surgery Market 14
(Date:8/27/2014)... (PRWEB) August 28, 2014 National ... participate in the Association for Medical Education in Europe ... in Milan, Italy August 30 – September 3, 2014. ... of the international medical education community, share the benefits ... to strengthen resident physician placement in countries throughout the ...
(Date:8/27/2014)... When it comes to the bedroom, most ... sleep without breaking the bank in the process. Regardless of ... mattress set for the master bedroom or simply looking for ... it all during their Labor Day mattress promotion. , This ... best mattresses for the home, while enjoying free delivery. Beyond ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 Millennium Treatment ... a sponsor for Florida Mental Health Counselors Association (FMHCA). ... the new sponsorship is sure to provide. , FMHCA ... needs of Florida’s licensed mental health counselors. The organization ... American Counseling Association (ACA) and since then, it has ...
(Date:8/27/2014)... City, UT (PRWEB) August 27, 2014 ... announces a webinar on compliance tips for administering a ... with health reform in full effect, compliance is top ... As employers transition to individual health insurance and premium ... comply with. , In the 35 minute webinar, Zane ...
(Date:8/27/2014)... Recently, iFitDress.com, a professional company of women’s dresses ... romantic bridal gowns . To top it all ... to 66 percent off) when buying the company’s new ... been updated with these new items. All its online ... all clients can gain an enjoyable shopping experience on ...
Breaking Medicine News(10 mins):Health News:National Resident Matching Program International (NRMPI) to Exhibit at the 2014 AMEE Conference 2Health News:Bedding Mart, Top Mattress Store in Broken Arrow Oklahoma, Announces a Huge Labor Day Sale 2Health News:Millennium Treatment Group Sponsors Florida Mental Health Counselors Association 2Health News:Zane Benefits Announces Upcoming Webinar on Compliance 2Health News:Promotion For Romantic Bridal Gowns Launched By Professional Company iFitDress.com 2
... a new strategy for quicker and more precise detection of ... the way for new tools to detect early stages of ... diseases have proteins specifically linked to them called biomarkers. Identifying ... powerful tool in identifying diseases in their early stages. This ...
... confectionary owes as much to art as it does ... handcraft with large scale industry. Confectionery and ... years of Professor Ferenc Mohos, inside experience to reveal ... applied to this unique industry. "Confectionery is usually ...
... BOSTONThe risk factors for indoor and outdoor falls for older ... Institute for Aging Research of Hebrew SeniorLife, an affiliate of ... the two are combined and may affect how falls prevention ... says senior author Marian T. Hannan, D.Sc., a senior scientist ...
... cancer researchers have identified a genetic signature that ... cell lung cancer,are at high risk for developing ... surgery ("adjuvant chemotherapy"). , "The findings give ... the,appropriate post-operative treatment route to follow. Not all ...
... HealthDay Reporter , TUESDAY, Sept. 7 (HealthDay News) ... have been limited by concerns over the possible development of ... to prevent their infection in the first place. But ... may be a way to administer one particularly cheap and ...
... of Rochester Medical Center researchers are beginning a large, ... prevention program in high schools across New York and ... Sources of Strength, led by Peter Wyman, Ph.D., associate ... by a five-year, $3-million grant awarded by the National ...
Cached Medicine News:Health News:Scientists make leap forward in early detection for Alzheimer's and cancer 2Health News:Confectionery and chocolate engineering: Principles and applications 2Health News:Institute for Aging Research study finds indoor and outdoor fall are different for the elderly 2Health News:Institute for Aging Research study finds indoor and outdoor fall are different for the elderly 3Health News:Researchers identify gene set that shows which patients benefit from chemo after surgery 2Health News:Many HIV-Infected Kids Could Use Cheaper Treatment Safely 2Health News:Many HIV-Infected Kids Could Use Cheaper Treatment Safely 3Health News:Many HIV-Infected Kids Could Use Cheaper Treatment Safely 4Health News:Researchers will test suicide prevention program in high schools 2Health News:Researchers will test suicide prevention program in high schools 3
... polyester, latex-free, thermal transfer wristband for ... Prints images that resist smears and ... mild cleaners, and blood. A time-tested ... and patron management applications. A tamper-evident ...
... thermal wristband that provides automated ID verification ... boost efficiency and accuracy. Meets healthcare patient ... the risk of data left on ribbons ... errors (FDA). Also available with UV varnish, ...
... Laser Sheeted Wristband / ... laser-printable sheets with an ... laser labels that adhere ... clear, fold-over protective window ...
... DataMate Laser Sheeted Wristband ... of laser-printable sheets with ... and laser labels that ... wristbands clear, fold-over protective ...
Medicine Products: